on Friday, December 7, 2012
Neuropathologist and scientist Jason T. Huse has been selected by the Sontag Foundation as one of three Distinguished Scientist Award recipients for 2012. The annual award is given to researchers of outstanding promise who are early in their careers, with the goal of accelerating independent research in the field of brain cancer.
In his research, Dr. Huse aims to identify the molecular determinants of malignant gliomas and translate his findings to the clinic in the form of advanced diagnostic testing. His preliminary work has already identified a specific microRNA, miR-34a, as central to the biology of low-grade gliomas — which over time inevitably become metastatic high-grade gliomas, and fatal.
Dr. Huse’s career goal is to significantly change the management of brain cancer for the better.
The Sontag Foundation is a family foundation based in Florida with a mission to fund biomedical research. Its scientific advisory board and a layperson committee review the applications for the annual Distinguished Scientist Award, for which recipients receive $600,000 in funding over a four-year period.